K. Nakagawa et al., Donor dendritic cells and recipient kupffer cells in the induction of donor-specific immune hyporesponsiveness, J INT MED R, 29(2), 2001, pp. 119-130
Citations number
47
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research General Topics
The aim of this study was to investigate the ability of portovenously admin
istered donor antigens to induce immune hyporesponsiveness. Lewis (LEW, RT-
1(1)) rats received Brown Norway (BN, RT-1(n)) rat donor splenocytes, via e
ither the portal vein (PV group) or the peripheral vein (IV group). The imm
une responses of LEW rats, treated with either donor BN or third party Wist
ar King A (WKA, RT-1(k)) splenocytes were established by the persistence of
donor dendritic cells (DCs) in the host liver measured using fluorescence
microscopy and flow cytometry and by the mixed lymphocyte reaction (MLR). T
he effect of intravenous gadolinium chloride (GDCl(3)) on the blockade of K
upffer cell function prior to portovenous administration of splenocytes was
also assessed. The MLR response was strongly inhibited in a BN-restricted
manner after portovenous administration of donor BN splenocytes, but not by
venous nor by portovenous administration of WKA splenocytes. Immunosuppres
sion was blocked by pretreatment with GDCl(3). The percentage of donor DCs
in hepatic non-parenchymal cells (NPCs) was significantly higher in the PV
group compared with the IV group. Treatment with GDCl(3) decreased the perc
entage of donor DCs. In addition, cytotoxic T lymphocyte antigen 4(CTLA4/CD
152), which may function as an immune attenuator, was strongly stained, and
B7 was weakly stained in recipient liver in the PV group compared with the
IV group. These results suggest that both donor DCs and recipient Kupffer
cells (self DCs) are involved in the induction of immune hyporesponsiveness
by donor cells. This occurs via portovenous administration, in which a sig
nal of the CTLA4-B7 pathway played an important part in inhibiting the inte
raction of CD28 and its B7 ligands.